Kokilaben Soni

Kokilaben Soni

Active Director Director DIN 06656994
DIN 06656994 First appointment Aug 2013 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2013
Shareholding value •••• Premium profile

About Kokilaben Soni

Data last updated:

Kokilaben Soni is a Director at Excelleza Clinical Trial Solutions Private Limited (since 2013). The company operates in Service. Excelleza Clinical Trial Solutions Private Limited reported revenue of ₹13.9 Lakh (FY 2025).

DIN 06656994
Primary Designation Director
Industry Service
First Appointment 12 Aug 2013
Oldest Company Age 16 yrs
Largest company Excelleza Clinical Trial Solutions Private Limited · ₹13.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Aug 20132010₹13.9 Lakh (FY 2025)Active

Board colleagues of Kokilaben Soni

Directorship timeline

Open interactive timeline →
Excelleza Clinical Trial Solutions Private Limited
Premium access

Shareholding and investment profile for Kokilaben Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kokilaben Soni

Kokilaben Soni currently holds 1 directorship: Excelleza Clinical Trial Solutions Private Limited (Director, since 12 Aug 2013, revenue ₹13.9 Lakh (FY 2025)).

Kokilaben Soni was first appointed on 12 Aug 2013 as Director at Excelleza Clinical Trial Solutions Private Limited.

The current boards of Kokilaben Soni's companies include Rupa Ameet Soni (Excelleza Clinical Trial Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available